AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2014
Dec 5, 2014
30786_dirs_2014-12-04_632ce21f-1660-4f50-8bee-920fa7f102bb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2014-12-02
Reporting Person: SODERBERG SHAWN MARIE (EVP, General Counsel, Sec)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-02 | Bio-Rad A Common Stock | M | 217 | — | Acquired | 266.3787 | Direct |
| 2014-12-03 | Bio-Rad A Common Stock | S | 83 | $120.00 | Disposed | 183.3787 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-02 | Restricted Stock Units | $0 | M | 217 | Disposed | Bio-Rad A Common Stock (217) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Includes 49.3787 shares acquired under the Bio-Rad Laboratories employee stock purchase plan on 9/30/2014.
F3: Sold by the Issuer on behalf of the Reporting Person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.
F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5: The restricted stock units vest in five equal annual installments beginning December 2, 2014.